BACKGROUNDVarious adjuvants are being used with local anaesthetics for prolongation of intraoperative and postoperative analgesia. This study was taken up to compare the duration of postoperative analgesia, extent of motor and sensory block, adverse effects along with the haemodynamic changes between ropivacaine alone, ropivacaine with clonidine and ropivacaine with dexmedetomidine.
BACKGROUND Dilated cardiomyopathy (DCM) is a form of cardiomyopathy characterised by left ventricular or biventricular dilatation and impaired ventricular contractility. Peripartum cardiomyopathy (PPCM) is a disease affecting the parturient during late pregnancy or immediately after delivery. It has an incidence of one per 3500 live births and is associated with a high mortality rate (30-60%). [1] The major concern while managing these patients is to optimise fluid administration and avoid myocardial depression, while maintaining stable intraoperative haemodynamics. Seizure disorders are 2 nd most prevalent and most serious neurological conditions encountered in pregnant women after migraine. Epilepsy can affect the course of pregnancy, labour, delivery and alter the foetal development whereas pregnancy can exacerbate epilepsy. [2,3] Metabolism of antiepileptic medications during pregnancy is changed and teratogenic effects of several anticonvulsant medications are unquestioned. Anaesthetic management of such cases poses a challenge due to the increased risk of various perioperative complications. We report the successful anaesthetic management of a patient with PPCM and seizure disorder posted for Suction Evacuation with Sterilisation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.